Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis

Jia-Feng Wang1, Wei Cai2, Fen-Sheng Qiu1

  • 1Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China.

Insights

N6-methyladenosine (m6A) RNA modification impacts viral replication and host immunity. Understanding m6A

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Virology

Background:

  • N6-methyladenosine (m6A) is a widespread RNA modification in various organisms, influencing RNA's structure, localization, and function.
  • m6A sites are found in viral RNA genomes and DNA virus transcripts, playing a role during primary infection.
  • This modification is dynamically regulated by writers, erasers, and readers within host cells.

Purpose of the Study:

  • To review recent advances in understanding m6A modification in viral replication.
  • To explore the role of m6A in host immune response during viral infections.
  • To highlight m6A's contribution to virus-induced carcinogenesis and potential epigenetic prevention strategies.

Main Methods:

  • Literature review of recent studies on m6A modification in viral contexts.
  • Analysis of mechanisms linking m6A to viral replication, host immunity, and cancer development.
  • Synthesis of findings to provide insights into epigenetic strategies.

Main Results:

  • m6A modification is dynamically regulated during viral infection by host cellular machinery.
  • Aberrant m6A patterns affect pathogenic viral replication and modulate host immune responses.
  • m6A dysregulation is implicated in the pathogenesis of virus-associated cancers.

Conclusions:

  • m6A modification is a critical epigenetic regulator in virus-host interactions.
  • Targeting m6A pathways offers potential for novel antiviral therapies and cancer prevention.
  • Further research into m6A mechanisms can illuminate new avenues for epigenetic interventions.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K